UNITEDHEALTH GROUP

UNH
Delayed Quote. Delayed  - 01/26 04:10:00 pm
343.11USD -1.35%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 242 155257 141
EBITDA1 22 40525 296
Operating profit (EBIT)1 19 68522 405
Operating Margin 8,13%8,71%
Pre-Tax Profit (EBT)1 17 98120 742
Net income1 13 83915 403
Net margin 5,71%5,99%
EPS2 14,316,0
Dividend per Share2 4,144,71
Last update 01/15/202001/20/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 29 69326 546
Net Cash position1 --
Leverage (Debt / EBITDA) 1,33x1,05x
Free Cash Flow1 16 39220 123
ROE (Net Profit / Equities) 25,7%24,9%
Shareholders' equity1 53 84861 859
ROA (Net Profit / Asset) 8,48%8,30%
Assets1 163 196185 589
Book Value Per Share2 60,868,8
Cash Flow per Share2 19,123,1
Capex1 2 0712 051
Capex / Sales 0,86%0,80%
Last update 01/15/202001/20/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 325 550 M $ -
Entreprise Value (EV) 350 085 M $ 345 504 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 21,4x 19,8x
Capitalization / Revenue 1,27x 1,17x
EV / Revenue 1,36x 1,26x
EV / EBITDA 13,9x 13,4x
Yield (DPS / Price) 1,37% 1,47%
Price to book (Price / BVPS) 4,88x 4,31x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 8,63% 8,23%
Operating Leverage (Delta EBIT / Delta Sales) 2,11x 0,42x
Net Margin (Net Profit / Revenue) 5,99% 5,92%
ROA (Net Profit / Asset) 8,62% 8,45%
ROE (Net Profit / Equities) 25,1% 23,9%
Rate of Dividend 29,4% 29,0%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   0,84% 0,85%
Cash Flow / Sales 7,71% 7,38%
Capital Intensity (Assets / Sales) 0,69x 0,70x
Financial Leverage (Net Debt / EBITDA) 0,97x 0,76x
Price Earning Ratio
EPS & Dividend